Proton Pump Inhibitors and Histamine-2 Receptor Antagonists Are Associated With Hip Fractures Among At-Risk Patients
- 1 July 2010
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 139 (1) , 93-101
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 DK63616)
This publication has 36 references indexed in Scilit:
- Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older AdultsCalcified Tissue International, 2008
- Use of proton pump inhibitors and risk of osteoporosis-related fracturesCanadian Medical Association Journal, 2008
- Factors Associated With 5-Year Risk of Hip Fracture in Postmenopausal WomenJAMA, 2007
- Hip fractureBMJ, 2006
- Acidification of the Osteoclastic Resorption Compartment Provides Insight into the Coupling of Bone Formation to Bone ResorptionThe American Journal of Pathology, 2005
- Calcium and Phosphate Plasma Levels in Dialysis Patients after Dietary Ca-P OverloadNephron, 2002
- Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans.Journal of the American College of Nutrition, 1995
- Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humansCalcified Tissue International, 1993
- Applied Logistic RegressionTechnometrics, 1992
- Calcium Absorption and AchlorhydriaNew England Journal of Medicine, 1985